| Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics R Schmitz, RM Young, M Ceribelli, S Jhavar, W Xiao, M Zhang, G Wright, ... Nature 490 (7418), 116-120, 2012 | 707 | 2012 |
| Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma Y Yang, AL Shaffer III, NCT Emre, M Ceribelli, M Zhang, G Wright, W Xiao, ... Cancer cell 21 (6), 723-737, 2012 | 449 | 2012 |
| Inhibition of B cell receptor signaling by ibrutinib in primary CNS lymphoma MS Lionakis, K Dunleavy, M Roschewski, BC Widemann, JA Butman, ... Cancer cell 31 (6), 833-843. e5, 2017 | 231 | 2017 |
| Oncogenic mechanisms in Burkitt lymphoma R Schmitz, M Ceribelli, S Pittaluga, G Wright, LM Staudt Cold Spring Harbor perspectives in medicine 4 (2), a014282, 2014 | 173 | 2014 |
| Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors M Ceribelli, PN Kelly, AL Shaffer, GW Wright, W Xiao, Y Yang, LAM Griner, ... Proceedings of the National Academy of Sciences 111 (31), 11365-11370, 2014 | 151 | 2014 |
| The THAP–zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes C Cayrol, C Lacroix, C Mathe, V Ecochard, M Ceribelli, E Loreau, V Lazar, ... Blood 109 (2), 584-594, 2007 | 135 | 2007 |
| Malignant pirates of the immune system L Rui, R Schmitz, M Ceribelli, LM Staudt Nature immunology 12 (10), 933-940, 2011 | 131 | 2011 |
| The histone-like NF-Y is a bifunctional transcription factor M Ceribelli, D Dolfini, D Merico, R Gatta, AM Viganò, G Pavesi, ... Molecular and cellular biology 28 (6), 2047-2058, 2008 | 130 | 2008 |
| A multiprotein supercomplex controlling oncogenic signalling in lymphoma JD Phelan, RM Young, DE Webster, S Roulland, GW Wright, M Kasbekar, ... Nature 560 (7718), 387-391, 2018 | 126 | 2018 |
| Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms Y Yang, R Schmitz, J Mitala, A Whiting, W Xiao, M Ceribelli, GW Wright, ... Cancer discovery 4 (4), 480-493, 2014 | 124 | 2014 |
| A druggable TCF4-and BRD4-dependent transcriptional network sustains malignancy in blastic plasmacytoid dendritic cell neoplasm M Ceribelli, ZE Hou, PN Kelly, G Wright, K Ganapathi, MO Evbuomwan, ... Cancer cell 30 (5), 764-778, 2016 | 86 | 2016 |
| Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells CM Sawai, V Sisirak, HS Ghosh, EZ Hou, M Ceribelli, LM Staudt, B Reizis Journal of Experimental Medicine 210 (11), 2151-2159, 2013 | 83 | 2013 |
| Targeting non-proteolytic protein ubiquitination for the treatment of diffuse large B cell lymphoma Y Yang, P Kelly, AL Shaffer III, R Schmitz, HM Yoo, X Liu, D Webster, ... Cancer cell 29 (4), 494-507, 2016 | 74 | 2016 |
| Repression of new p53 targets revealed by ChIP on chip experiments M Ceribelli, M Alcalay, MA Viganò, R Mantovani Cell Cycle 5 (10), 1102-1110, 2006 | 63 | 2006 |
| Selective effects of the anticancer drug Yondelis (ET-743) on cell-cycle promoters M Minuzzo, M Ceribelli, M Pitarque-Martì, S Borrelli, E Erba, M D'Incalci, ... Molecular pharmacology 68 (5), 1496-1503, 2005 | 52 | 2005 |
| Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma M Chiorazzi, L Rui, Y Yang, M Ceribelli, N Tishbi, CW Maurer, ... Proceedings of the National Academy of Sciences 110 (10), 3943-3948, 2013 | 46 | 2013 |
| Isoform-specific expression and feedback regulation of E protein TCF4 control dendritic cell lineage specification LT Grajkowska, M Ceribelli, CM Lau, ME Warren, I Tiniakou, SN Higa, ... Immunity 46 (1), 65-77, 2017 | 43 | 2017 |
| Targeting the HTLV-I-regulated BATF3/IRF4 transcriptional network in adult T cell leukemia/lymphoma M Nakagawa, AL Shaffer III, M Ceribelli, M Zhang, G Wright, W Xiao, ... Cancer Cell 34 (2), 286-297. e10, 2018 | 39 | 2018 |
| Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma L Rui, AC Drennan, M Ceribelli, F Zhu, GW Wright, W Xiao, Y Li, ... Proceedings of the National Academy of Sciences 113 (46), E7260-E7267, 2016 | 38 | 2016 |
| Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening GL Lin, KM Wilson, M Ceribelli, BZ Stanton, PJ Woo, S Kreimer, EY Qin, ... Science translational medicine 11 (519), 2019 | 37 | 2019 |
Arthur L. ShafferNIH NCI CCR Lymphoid Malignancies BranchVerified email at mail.nih.gov
